InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 09/08/2020 9:16:06 PM

Tuesday, September 08, 2020 9:16:06 PM

Post# of 5907
Just In: $AVEO AVEO Oncology Regains Full Global Rights to Ficlatuzumab

Announces Decision to Fund Clinical Manufacture of Ficlatuzumab for Potential Phase 3 Study and Update to Biodesix Partnership No Change to AVEO Cash Runway Guidance AVEO Oncology (Nasdaq: AVEO) today announced that it has regained full global rights to ficlatuzumab, AVEO’...

Got this from AVEO - AVEO Oncology Regains Full Global Rights to Ficlatuzumab